UnitedHealth Group stock falls after Senate report alleges aggressive tactics in Medicare payments.

UnitedHealth Group's stock fell up to 3.1% premarket on Monday after a Senate committee reported that the company used "aggressive tactics" to collect payment-boosting diagnoses for Medicare patients. The investigation found that UnitedHealth deployed tactics to secure payments for diagnoses that may not have been justified, leading to increased costs for Medicare.